2016 International Congress

June 19-23, 2016. Berlin, Germany.

View by Title View Sessions

View by Date

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

Incidental finding of drug-induced movement disorder

G. Avagyan, H. Manvelyan, A. Nazaryan (Yerevan, Armenia)
Increase L-dopa dosage for rest tremor or think about the essential tremor too?

A. Voskanyan, G. Avagyan, E. Khachatryan, K. Harutyunyan, S. Khachaturyan, H. Amirjanyan, H. Manvelyan (Yerevan, Armenia)
Increased access to training in a Parkinson-specific rehabilitation approach through online learning

C. Fox, L. Guse, L. Ramig (Tucson, AZ, USA)
Increased anti-MAG autoantibodies titers in Parkinson’s disease

E. Papuc, K. Rejdak (Lublin, Poland)
Increased cellular co-localization of tau fragment 1-368 and alpha-synuclein in two mouse model of Parkinson’s disease

K. Ma, S. Nie, G. Chen, C. Han, X. Guo, Y. Xu, X. Cao (Wuhan, People's Republic of China)
Increased cerebrospinal fluid lactate levels in Parkison’s disease: Is it a proof of mitochondrial inefficiency?

C. Liguori, A. Stefani, E. Olivola, N.B. Mercuri, M. Pierantozzi (Rome, Italy)
Increased cortical control of gait in patients with Parkinson’s disease and freezing of gait

G.J. Revuelta, C. Chan, S. Jenkins, J. Jensen, L. Bonilha (Charleston, SC, USA)
Increased energy expenditure in early Parkinson’s disease during exercise

T. Margaliot Kalifa, N. Ziv, H. Bergman, S. Nusair, D. Arkadir (Jerusalem, Israel)
Increased monosaccharide intake in patients with Parkinson’s disease

E. Schaeffer, A. Schermann, F. Zirbs, D. Berg (Tübingen, Germany)
Increasing placebo response in Parkinson’s disease through apomorphine pre-conditioning

E. Frisaldi, E. Carlino, L. Giudetti, A. Pampallona, M. Zibetti, M. Lanotte, L. Lopiano, F. Benedetti (Turin, Italy)

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z